A61K 31/5377
Not condensed and containing further heterocyclic rings
Official title: not condensed and containing further heterocyclic rings, e.g. timolol
A61K31/5377 (Not condensed and containing further heterocyclic rings) appears on 6,623 US grants and 12,039 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,623
- Published applications
- 12,039
- Assignees
- 3,240
- Inventors
- 24,212
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 6 | 0 |
| 1996 | 15 | 0 |
| 1997 | 28 | 0 |
| 1998 | 24 | 0 |
| 1999 | 27 | 0 |
| 2000 | 41 | 0 |
| 2001 | 37 | 17 |
| 2002 | 38 | 64 |
| 2003 | 45 | 119 |
| 2004 | 44 | 117 |
| 2005 | 35 | 135 |
| 2006 | 51 | 165 |
| 2007 | 45 | 159 |
| 2008 | 66 | 140 |
| 2009 | 72 | 213 |
| 2010 | 75 | 253 |
| 2011 | 115 | 315 |
| 2012 | 183 | 330 |
| 2013 | 283 | 597 |
| 2014 | 389 | 746 |
| 2015 | 498 | 835 |
| 2016 | 560 | 833 |
| 2017 | 630 | 793 |
| 2018 | 542 | 684 |
| 2019 | 539 | 654 |
| 2020 | 429 | 641 |
| 2021 | 365 | 646 |
| 2022 | 314 | 610 |
| 2023 | 268 | 626 |
| 2024 | 306 | 782 |
| 2025 | 321 | 852 |
| 2026 | 228 | 713 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- Combination therapy of PD-1 axis binding antagonists and LRRK2 inhitibors6 Oct 2026US 12,751,956 B2Hoffmann-La Roche Inc.
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Compositions and methods of treating lupus nephritis6 Oct 2026US 12,752,005 B2Genentech, Inc.
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Inverse agonists of rar related orphan receptors (rors)8 Oct 2026US 2026/0306484 A111949098 CANADA INC. (NUREDCO) c/o Jean I. TCHERVENKOV
- Pim1 inhibitor for treating myeloproliferative neoplasms8 Oct 2026US 2026/0306490 A1Sumitomo Pharma America, Inc.
- Mitochondrial uncouplers for treatment of metabolic diseases and cancer8 Oct 2026US 2026/0306502 A1Mito Biopharma, LLC
- (s)-2-hydroxy-6-((4-(2-(2-hydroxyethyl)nicotinoyl)morpholin-3-yl)methoxy)benzaldehyd for use in the treatment of sickle cell disease8 Oct 2026US 2026/0306503 A1Global Blood Therapeutics, Inc.
- Plasmin-induced internal limiting membrane digestion facilitates donor retinal ganglion cell transplantation8 Oct 2026US 2026/0306549 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
Most cited
By later US patents
- Treatment of female sexual dysfunction239US 5,877,216 AVivus, Inc. · 1999
- Treatment of female sexual dysfunction233US 6,294,550 B1Asivi, LLC · 2001
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Treatment of female sexual dysfunction212US 6,306,841 B1Asivi, LLC · 2001
- Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase198US 5,710,158 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998